Rigel Pharma (RIGL) Tops Q2 EPS by 5c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $40.90 -0.66%
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
LEDS, DSNY, SPRS, More
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
LEDS, DSNY, SPRS, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q2 EPS of ($0.15), $0.05 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $8.6 million versus the consensus estimate of $4.01 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SK Hynix vs. Micron deep dive: who wins the AI memory supercycle?
- Erste Group Downgrades Marvell (MRVL) to Hold
- SemiLEDS (LEDS) Tops Q3 EPS by 18c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
